Apex Healthcare Berhad's latest marketcap:
As of 07/19/2025, Apex Healthcare Berhad's market capitalization has reached $403.99 M. According to our data, Apex Healthcare Berhad is the 15686th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 403.99 M |
| Revenue (ttm) | 224.43 M |
| Net Income (ttm) | 17.18 M |
| Shares Out | 720.39 M |
| EPS (ttm) | 0.02 |
| Forward PE | 19.72 |
| Ex-Dividend Date | 05/30/2025 |
| Earnings Date | 08/20/2025 |
Apex Healthcare Berhad's yearly market capitalization.
| Date | Market Cap(RM) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/19/2025 | RM1.71 B | $403.99 M | -4.43% | 15686 |
| 12/31/2024 | RM1.78 B | $396.89 M | -0.55% | 14524 |
| 12/29/2023 | RM1.79 B | $388.87 M | 6.4% | 14699 |
| 12/30/2022 | RM1.68 B | $380.93 M | 31.22% | 14002 |
| 12/31/2021 | RM1.28 B | $306.83 M | -23.83% | 16332 |
| 12/31/2020 | RM1.68 B | $417.26 M | 59.11% | 12619 |
| 12/31/2019 | RM1.06 B | $257.8 M | 15.28% | 13534 |
| 12/31/2018 | RM916.86 M | $221.42 M | 39.76% | 13425 |
| 12/29/2017 | RM656.02 M | $161.77 M | 30.23% | 15573 |
| 12/30/2016 | RM503.73 M | $112.03 M | 19.44% | 15406 |
Company Profile
Apex Healthcare Berhad Overview
Apex Healthcare Berhad is an investment holding company specializing in the development, manufacture, marketing, and distribution of pharmaceutical and healthcare products. The company operates primarily in Malaysia, Singapore, and internationally.
Business Segments
- Manufacturing: Produces a wide range of pharmaceutical products under the Xepa brand, including tablets, capsules, oral liquids, creams, and sterile eye drops.
- Distribution: Engages in wholesaling and retailing pharmaceutical and healthcare products.
- Corporate: Handles property rental, brand management, and consultancy services.
Product Offerings
The company provides diverse healthcare solutions, such as:
- Cough mixtures and antihistamines
- Anti-infective and anti-diabetic medications
- Anti-hypertensive and neuromuscular agents
- Analgesics, dermatological, and ophthalmological products
Additional Operations
- Contract manufacturing of surgical-grade orthopedic devices and instruments.
- Commercialization of pharmaceuticals and medical devices under the Zynexis brand.
- Retail pharmacy services and property management.
Founded: 1962
Headquarters: Malacca, Malaysia
Frequently Asked Questions
-
What is Apex Healthcare Berhad's (KLSE-AHEALTH) current market cap?As of 07/19/2025, Apex Healthcare Berhad (including the parent company, if applicable) has an estimated market capitalization of $403.99 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Apex Healthcare Berhad (KLSE-AHEALTH) rank globally by market cap?Apex Healthcare Berhad global market capitalization ranking is approximately 15686 as of 07/19/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.